[The role of FDG-PET scan in the diagnosis of pancreatic carcinoma]

Orv Hetil. 2002 May 26;143(21 Suppl 3):1283-6.
[Article in Hungarian]

Abstract

In 22 patients with focal pancreatic lesions, the values of different diagnostic modalities were analysed for the evaluation of malignancy. The CA 19-9 level was elevated in 4/5 malignant cases (sensitivity: 80%) and in 4/15 of benign cases (specificity: 73%). Hypodensity/hypoechogeneity was considered to be the characteristic sign of malignancy during CT/ultrasound (sensitivity: 100%, specificity: 50%/47%). ERCP was found to be specific but not sensitive enough and the rate of unsuccessful investigations was relatively high (4/22). The diagnostic value of FDG-PET was found to be superior to other diagnostic modalities (sensitivity 100%, specificity 88%). In cases with focal pancreatic hypoechogenic/hypodense lesions detected by CT or US in suspicion of malignancy, the FDG-PET should be the next step in the diagnostic strategy.

MeSH terms

  • Adult
  • CA-19-9 Antigen / blood
  • Carcinoma / blood
  • Carcinoma / diagnostic imaging*
  • Cholangiopancreatography, Endoscopic Retrograde
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / blood
  • Pancreatic Neoplasms / diagnostic imaging*
  • Pancreatitis / diagnostic imaging
  • Predictive Value of Tests
  • Radiopharmaceuticals
  • Retrospective Studies
  • Sensitivity and Specificity
  • Tomography, Emission-Computed* / methods
  • Tomography, X-Ray Computed
  • Ultrasonography

Substances

  • CA-19-9 Antigen
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18